Twitxy Saved

Jason Liu, MD

@JasonRLiuMD

Radiation Oncologist at @COH_RadOnc serving the lovely communities of South Pasadena & Glendale
South Pasadena, CA cityofhope.org/jason-liu Joined August 2020
285 Following 494 Followers 211 Posts

Latest posts 5

Jason Liu, MD @JasonRLiuMD
More dose was not better in definitive ESCC. Three-year PFS: 45% with 50.4 Gy vs 26% with 60 Gy (phase 2, n=97), but the difference vanished after covariate adjustment. Single-center trial using S-1/nedaplatin. No support for escalation.
pubmed.ncbi.nlm.nih.gov/42537853/
pubmed.ncbi.nlm.nih.gov A Phase 2 Randomized Trial Comparing Radiation Doses in Concurrent Chemoradiotherapy With TS-1/Ne... A radiation dose of 50.4 Gy remains the standard dose in concurrent CRT for esophageal squamous cell carcinoma.